期刊文献+

人源化抗VEGF单克隆抗体制品的大小异质性分析 被引量:3

Size heterogeneity analysis of monoclonal antibody products
原文传递
导出
摘要 目的:比较十二烷基磺酸钠聚丙烯酰胺凝胶电泳(sodiumdodecylsulfatepolyacrylam-idegelelectrophoresis,CE-SDS)和分子排阻高效液相(sizeexclusionhighperformanceliquidchromatogra-phy,SE-HPLC)在单克隆抗体(单抗)大小异质性分析中的区别。方法应用非还原和还原CE-SDS以及常规、变性和变性还原SE-HPLC评价人源化抗血管内皮细胞生长因子(VEGF)单抗的大小异质性。结果对于多聚体的分析,虽然非还原CE-SDS结果显示其含量为0.82%±0.01%,显著低于常规SE-HPLC的分析结果(5.08%±0.10%),但与变性SE-HPLC的分析结果(1.05%±0.02%)则基本一致;在非还原状态下对单抗的片段分析,非还原CE-SDS结果显示其含量为7.12%±0.04%,显著高于常规SE-HPLC的分析结果(0.02%±0.01%)以及变性SE-HPLC的分析结果(0.62%±0.01%);而在还原状态下对单抗的片段分析,还原CE-SDS结果显示其含量为(3.19%±0.50%),其含量同样高于变性还原SE-HPLC的分析结果(0.07%±0.01%)。结论在分析多聚体含量时,由于常规SE-HPLC对共价和非共价连接的多聚体形式均可显示,相比CE-SDS相比更加客观;而在分析片段含量时,非还原CE-SDS可显示非共价键连接的片段,还原CE-SDS可显示降解片段,所以CE-SDS相比常规SE-HPLC更具优势。两种不同原理分析方法的组合有效保障了单抗制品大小异质性的质量控制。 Objective To compare the capability of capillary electrophoresis-sodium dodecyl sul-fate ( CE-SDS) and size exclusion-high performance liquid chromatography ( SE-HPLC) for analysis of size heterogeneity of monoclonal antibody products .Methods The size heterogeneity of one humanized anti-VEGF monoclonal antibody was analyzed by using non-reduced and reduced CE-SDS, and conventional , de-natured and denatured reduced SE-HPLC.Results The percentage of aggregates detected by non-reduced CE-SDS (0.82%±0.01%) was equal to that by using denatured SE-HPLC (1.05%±0.02%), but it was significantly lower than that by using conventional SE-HPLC analysis (5.08%±0.10%).With regard to fragments analyzed with non-reduced antibodies, its percentage was (7.12±0.04)% measured by non-re-duced CE-SDS analysis that was significantly higher than that by conventional SE -HPLC analysis (0.02%± 0.01%) and denatured SE-HPLC analysis (0.62%±0.01%).Using reduced antibodies , the percentage of fragments was (3.19±0.50)%tested by reduced CE-SDS analysis that was significantly higher than that by using denatured reduced SE-HPLC analysis (0.07%±0.01%).Conclusion Conventional SE-HPLC was more objective than CE-SDS for content analysis of aggregates , as both the covalent and non-covalent forms of aggregates could be detected .Non-reduced CE-SDS could demonstrate the content of clips , while reduced CE-SDS showed the degraded fragments .Therefore, CE-SDS had an advantage over conventional SE-HPLC for content analysis of fragments .The use of the two analytical methods in combination provided solid techni-cal supports for the quality control of size heterogeneity of monoclonal antibodies .
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2014年第9期718-722,共5页 Chinese Journal of Microbiology and Immunology
关键词 单克隆抗体 大小异质性 CE—SDS SE—HPLC 多聚体 片段 Monoclonal antibody Size heterogeneity CE-SDS SE-HPLC Aggregate Fragment
  • 相关文献

参考文献12

  • 1Liu H, Gaza-Bulseco G, Faldu D, et al. Heterogeneity of monoelonal antibodies[J]. J Pharm Sci, 2008, 97(7) : 2426-2447.
  • 2Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies[ J]. MAbs, 2011, 3(3) : 253-263.
  • 3Lowe D, Dudgeon K, Rouet R, et al. Aggregation, stability, and formulation of human antibody therapeutics[ J]. Adv Protein Chem Struet Biol, 2011, 84: 41-61.
  • 4Chamberlain P. Assessing immunogenieity of biosimilar therapeutic monoelonal antibodies: regulatory and bioanalytical considerations [J]. Bioanalysis, 2013, 5(5): 561-574.
  • 5Gabrielson JP, Brader ML, Pekar AH, et al. Quantitation of aggregate levels in a recombinant humanized monoelonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fraetionation, and sedimentation velocity [ J ]. J Pharm Sci, 2007, 96(2) : 268-279.
  • 6Maeh H, Arvinte T. Addressing new analytical challenges in pro- tein formulation development [ J 1. Eur J Pharm Biopharm, 2011, 78(2) : 196-207.
  • 7Pekar A, Sukumar M. Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation : practical considerations that affect precision and accuracy [ J ]. Anal Biochem, 2007, 367(2) : 225-237.
  • 8Rustandi RR, Washabaugh MW, Wang Y. Applieations of CE SDS gel in development of biopharmaeeutical antibody-based prod- ucts[J]. Eleetrophoresis, 2008, 29(17): 3612-3620.
  • 9Van Buren N, Rehder D, Gadgil H, et al. Elucidation of two major aggregation pathways in an IgG2 antibody [ J ]. J Pharm Sei, 2009, 98(9) : 3013-3030.
  • 10Pathak M, Dutta D, Rathore A. Analytical QbD: Development of a native gel electrophoresis method for measurement of monoclonal antibody aggregates[ J ]. Eleetrophoresis, 2014, 35 ( 15 ) : 2163- 2171.

同被引文献13

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部